De-Escalation Strategies of (Chemo)Radiation for Head-and-Neck Squamous Cell Cancers—HPV and Beyond
Abstract: Oncological outcomes for head-and-neck squamous cell carcinoma (HNSCC) patients are still unsatisfactory, especially for advanced tumor stages. Besides the moderate survival rates, the prevalence of severe treatment-induced normal tissue toxicities is high after multimodal cancer treatments, both causing significant morbidity and decreasing quality of life of surviving patients. Therefore, risk-adapted and individualized treatment approaches are urgently needed for HNSCC patients to optimize the therapeutic gain. It has been a well-known fact that especially HPV-positive oropharyngeal squamous cell carcinoma (OSCC) patients exhibit an excellent prognosis and may therefore be subject to overtreatment, resulting in long-term treatment-related toxicities. Regarding the superior prognosis of HPV-positive OSCC patients, treatment de-escalation strategies are currently investigated in several clinical trials, and HPV-positive OSCC may potentially serve as a model for treatment de-escalation also for other types of HNSCC. We performed a literature search for both published and ongoing clinical trials and critically discussed the presented concepts and results. Radiotherapy dose or volume reduction, omission or modification of concomitant chemotherapy, and usage of induction chemotherapy are common treatment de-escalation strategies that are pursued in clinical trials for biologically selected subgroups of HNSCC patients. While promising data have been reported from various Phase II trials, evidence from Phase III de-escalation trials is either lacking or has failed to demonstrate comparable outcomes for de-escalated treatments. Therefore, further data and a refinement of biological HNSCC stratification are required before deescalated radiation treatments can be recommended outside of clinical trials
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
Cancers. - 13, 9 (2021) , 2204, ISSN: 2072-6694
- Event
-
Veröffentlichung
- (where)
-
Freiburg
- (who)
-
Universität
- (when)
-
2021
- DOI
-
10.3390/cancers13092204
- URN
-
urn:nbn:de:bsz:25-freidok-1949306
- Rights
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
25.03.2025, 1:52 PM CET
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Rühle, Alexander
- Grosu, Anca-Ligia
- Nicolay, Nils
- Universität
Time of origin
- 2021
Other Objects (12)
The distribution of the proteins involved in inositol-1,4,5-trisphosphate-mediated calcium release in the hippocampus : = Die Verteilung von Proteinen der inositol-1,4,5-trisphosphat-vermittelten Kalzium-Freisetzung im Hippocampus
Deeskalation der adjuvanten Radiotherapie nach transoraler Resektion HPV-positiver Oropharynxkarzinome: Ergebnisse der E3311-Studie : = De-escalation of adjuvant radiotherapy after transoral surgery of HPV-associated oropharyngeal cancer: results of the E3311 trial
Moderate Dosisdeeskalation der definitiven Cisplatin-basierten Radiochemotherapie für HPV-positive Oropharynxkarzinompatienten : : Ergebnisse der NRG-HN002-Studie = Moderate dose de-escalation of cisplatin-based chemoradiation for HPV-associated oropharyngeal carcinoma : results of the NRG-HN002 trial
Wöchentliche versus dreiwöchentliche Cisplatingabe bei der postoperativen Radiochemotherapie von lokal fortgeschrittenen Kopf-Hals-Plattenepithelkarzinomen – Ergebnisse der JCOG1008-Studie : = Weekly versus three-weekly cisplatin for the postoperative chemoradiation of locally advanced head-and-neck squamous cell carcinoma: results of the JCOG1008 trial
Sarcopenia as a prognostic marker in elderly head and neck squamous cell carcinoma patients undergoing (chemo-)radiation
Authors’ response to the letter to the editor by Busra Yilmaz and Ugur Selek regarding our study “The influence of antibiotic administration on the outcomes of head-and-neck squamous cell carcinoma patients undergoing definitive (chemo)radiation”
Authors’ response to the Letter to the Editor by Efsun Somay and Erkan Topkan regarding our study “The influence of antibiotic administration on the outcomes of head-and-neck squamous cell carcinoma patients undergoing definitive (chemo)radiation”
Bestrahlungsplan-Analysen bei Patientinnen mit bilateralen Mammakarzinomen : inzidentelle Dosisbelastungen und Toxizitäten im Vergleich verschiedener Bestrahlungsverfahren
Aggressive Deeskalation der Strahlentherapie bei HPV-assoziierten Oropharynxkarzinomen auf der Basis der Hypoxiedynamik
ORATOR2-Studie – randomisierter Vergleich einer primären Operation oder primären Strahlentherapie bei HPV-positivem Oropharynxkarzinom im Kontext einer Therapiedeeskalation : = ORATOR2 trial: randomized comparison of primary surgery vs. primary radiotherapy for HPV-associated oropharyngeal cancer in the context of de-escalated therapy
The particle radiobiology of multipotent mesenchymal stromal cells: a key to mitigating radiation-induced tissue toxicities in cancer treatment and beyond?
The influence of antibiotic administration on the outcomes of head-and-neck squamous cell carcinoma patients undergoing definitive (chemo)radiation
The distribution of the proteins involved in inositol-1,4,5-trisphosphate-mediated calcium release in the hippocampus : = Die Verteilung von Proteinen der inositol-1,4,5-trisphosphat-vermittelten Kalzium-Freisetzung im Hippocampus
Deeskalation der adjuvanten Radiotherapie nach transoraler Resektion HPV-positiver Oropharynxkarzinome: Ergebnisse der E3311-Studie : = De-escalation of adjuvant radiotherapy after transoral surgery of HPV-associated oropharyngeal cancer: results of the E3311 trial
Moderate Dosisdeeskalation der definitiven Cisplatin-basierten Radiochemotherapie für HPV-positive Oropharynxkarzinompatienten : : Ergebnisse der NRG-HN002-Studie = Moderate dose de-escalation of cisplatin-based chemoradiation for HPV-associated oropharyngeal carcinoma : results of the NRG-HN002 trial
Wöchentliche versus dreiwöchentliche Cisplatingabe bei der postoperativen Radiochemotherapie von lokal fortgeschrittenen Kopf-Hals-Plattenepithelkarzinomen – Ergebnisse der JCOG1008-Studie : = Weekly versus three-weekly cisplatin for the postoperative chemoradiation of locally advanced head-and-neck squamous cell carcinoma: results of the JCOG1008 trial
Sarcopenia as a prognostic marker in elderly head and neck squamous cell carcinoma patients undergoing (chemo-)radiation
Authors’ response to the letter to the editor by Busra Yilmaz and Ugur Selek regarding our study “The influence of antibiotic administration on the outcomes of head-and-neck squamous cell carcinoma patients undergoing definitive (chemo)radiation”
Authors’ response to the Letter to the Editor by Efsun Somay and Erkan Topkan regarding our study “The influence of antibiotic administration on the outcomes of head-and-neck squamous cell carcinoma patients undergoing definitive (chemo)radiation”
Bestrahlungsplan-Analysen bei Patientinnen mit bilateralen Mammakarzinomen : inzidentelle Dosisbelastungen und Toxizitäten im Vergleich verschiedener Bestrahlungsverfahren
Aggressive Deeskalation der Strahlentherapie bei HPV-assoziierten Oropharynxkarzinomen auf der Basis der Hypoxiedynamik
ORATOR2-Studie – randomisierter Vergleich einer primären Operation oder primären Strahlentherapie bei HPV-positivem Oropharynxkarzinom im Kontext einer Therapiedeeskalation : = ORATOR2 trial: randomized comparison of primary surgery vs. primary radiotherapy for HPV-associated oropharyngeal cancer in the context of de-escalated therapy
The particle radiobiology of multipotent mesenchymal stromal cells: a key to mitigating radiation-induced tissue toxicities in cancer treatment and beyond?
The influence of antibiotic administration on the outcomes of head-and-neck squamous cell carcinoma patients undergoing definitive (chemo)radiation
The distribution of the proteins involved in inositol-1,4,5-trisphosphate-mediated calcium release in the hippocampus : = Die Verteilung von Proteinen der inositol-1,4,5-trisphosphat-vermittelten Kalzium-Freisetzung im Hippocampus
Deeskalation der adjuvanten Radiotherapie nach transoraler Resektion HPV-positiver Oropharynxkarzinome: Ergebnisse der E3311-Studie : = De-escalation of adjuvant radiotherapy after transoral surgery of HPV-associated oropharyngeal cancer: results of the E3311 trial
Moderate Dosisdeeskalation der definitiven Cisplatin-basierten Radiochemotherapie für HPV-positive Oropharynxkarzinompatienten : : Ergebnisse der NRG-HN002-Studie = Moderate dose de-escalation of cisplatin-based chemoradiation for HPV-associated oropharyngeal carcinoma : results of the NRG-HN002 trial
Wöchentliche versus dreiwöchentliche Cisplatingabe bei der postoperativen Radiochemotherapie von lokal fortgeschrittenen Kopf-Hals-Plattenepithelkarzinomen – Ergebnisse der JCOG1008-Studie : = Weekly versus three-weekly cisplatin for the postoperative chemoradiation of locally advanced head-and-neck squamous cell carcinoma: results of the JCOG1008 trial
Sarcopenia as a prognostic marker in elderly head and neck squamous cell carcinoma patients undergoing (chemo-)radiation
Authors’ response to the letter to the editor by Busra Yilmaz and Ugur Selek regarding our study “The influence of antibiotic administration on the outcomes of head-and-neck squamous cell carcinoma patients undergoing definitive (chemo)radiation”
Authors’ response to the Letter to the Editor by Efsun Somay and Erkan Topkan regarding our study “The influence of antibiotic administration on the outcomes of head-and-neck squamous cell carcinoma patients undergoing definitive (chemo)radiation”
Bestrahlungsplan-Analysen bei Patientinnen mit bilateralen Mammakarzinomen : inzidentelle Dosisbelastungen und Toxizitäten im Vergleich verschiedener Bestrahlungsverfahren
Aggressive Deeskalation der Strahlentherapie bei HPV-assoziierten Oropharynxkarzinomen auf der Basis der Hypoxiedynamik
ORATOR2-Studie – randomisierter Vergleich einer primären Operation oder primären Strahlentherapie bei HPV-positivem Oropharynxkarzinom im Kontext einer Therapiedeeskalation : = ORATOR2 trial: randomized comparison of primary surgery vs. primary radiotherapy for HPV-associated oropharyngeal cancer in the context of de-escalated therapy
The particle radiobiology of multipotent mesenchymal stromal cells: a key to mitigating radiation-induced tissue toxicities in cancer treatment and beyond?